HYBRIDE ZUSAMMENSETZUNG

Patent europeic · EP3154599 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3154599
Numer da la dumonda
EP15729885
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
09-06-2015
Publitgà
19-04-2017
Concedì
14-08-2019
Stritgà
30-06-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61L 27/18 (2006.01)
A61L 27/22 (2006.01)
A61L 27/38 (2006.01)
Prioritad
GB 201410506 12.06.2014
Dumonda PCT
PCT/GB2015/051672 09.06.2015
Publicaziun PCT
WO2015/189586 17.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-01-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.01.2021

  2. 14-08-2019

    Concedì

    Published in Swissreg on 14.08.2019

Partidas

Possessur

Cell Therapy Limited

Institute of Life Sciences First Floor, Room 137 School of Medicine Swansea University Singleton Park, Swansea SA2 8PP, GB

Inventur

SULTAN, Sabena

Swansea West Glamorgan SA2 8PP, GB

EVANS, Martin John

Swansea West Glamorgan SA2 8PP, GB

REGINALD, Ajan

Swansea West Glamorgan SA2 8PP, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.